Selection of the Fellow will be on a competitive basis from a national pool of candidates with doctoral scientific and/or clinical training (e.g. PharmD or Ph.D.) and a demonstrated interest in health economics and/or outcomes research.
AN EQUAL OPPORTUNITY/AFFIRMATIVE ACTION EMPLOYER
It is university policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law. As an institution, we value diversity of background and opinion, and prohibit discrimination or harassment on the basis of any legally protected class in the areas of hiring, recruitment, promotion, transfer, demotion, training, compensation, pay, fringe benefits, layoff, termination or any other terms and conditions of employment. In compliance with the Americans with Disabilities Act (ADA), if you have a disability and would like to request an accommodation with regard to the application and selection processes (for example, the online application process or interviews) or have any questions about our website accessibility, please call 848-932-3973.
New Jersey First Act/Residency Law Any individual newly hired by Rutgers after September 1, 2011 will be required to abide by the New Jersey First Act/Residency Law and establish a principal residence in New Jersey, unless their position is on the exempt list or they successfully petition for exemption based on critical need or hardship. New employees will have a full 365 days to establish such residence, from
the effective date of hire. For additional information regarding this law visit the University Human Resources website at: http://uhr.rutgers.edu/new-jersey-first-actresidency-law
PUBLIC SAFETY INFORMATION: Information regarding public safety at Rutgers, The State University of New Jersey is available in the annual security report Safety Matters. For each of Rutgers' regional campuses, the report includes statistics for the previous three years concerning reported crimes that occurred on campus; in certain off-campus buildings or property owned or controlled by Rutgers University; and on public property within, or immediately adjacent to and accessible from, the campus. The report also includes institutional policies concerning campus security, such as policies concerning alcohol and drug use, crime prevention, the reporting of crimes, sexual assault, and other matters. “Safety Matters” is available online at: http://rupd.rutgers.edu/aboutsafe.shtml. A paper copy can be obtained at the RUPD headquarters on each campus or by emailing the APS Communications Director at clery@aps.rutgers.edu. The locations of the RUPD headquarters are: Camden Campus: 409 North 4th Street, Newark Campus: 200 University Avenue and New Brunswick Campus: 55 Commercial Avenue.
About Rutgers
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large. The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.
About GSK
GSK is a science-led global healthcare company with three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. GSK’s pharmaceutical business currently focuses on developing new medicines in respiratory and HIV/ infectious diseases, oncology and immuno-inflammation; with discovery research exploring these and other areas. The fellowship will be based in Upper Providence, Pennsylvania at GSK’s US R&D headquarters.